Search
My Stocks
SGX
Google
Yahoo
News
TradingView
IX BIOPHARMA LTD. (42C)
SGD 0.122
+0.82% +0.00
Portfolio
Watchlist
Divs
Anns
Trans
Notes
Articles
All
Financial
Buy Back
Insider Trading
2021-01-18
Change - Announcement of Appointment::Appointment of Chief Commercial Officer
2020-11-30
Annual Reports and Related Documents::
2020-11-20
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2020-11-10
General Announcement::Press Release: iX Biopharma receives positive EMA Scientific Advice for Wafermine
2020-10-30
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2020-10-30
General Announcement::MINUTES OF ANNUAL GENERAL MEETING HELD ON 16 OCTOBER 2020
2020-10-23
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN
2020-10-19
General Announcement::Press Release: iX Biopharma obtains approval and registration of Silcap in Singapore
2020-10-16
REPL::Annual General Meeting::Voluntary
2020-10-14
REPL::Annual General Meeting::Voluntary
2020-09-30
Annual Reports and Related Documents::
2020-09-30
Annual General Meeting::Voluntary
2020-09-27
General Announcement::Press Release: iX Biopharma Secures TGA GMP Licence for Its Testing Laboratory
2020-09-20
General Announcement::iX Biopharma Secures Israel Patent for Waferix Drug Delivery Technology
2020-09-10
REPL::Placements::PROPOSED PLACEMENT - COMPLETION OF PLACEMENT
2020-09-10
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2020-09-10
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2020-09-10
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2020-09-09
Placements::PROPOSED PLACEMENT - ALLOTMENT AND ISSUE OF SUBSCRIPTION SHARES
2020-09-07
REPL::Extraordinary/ Special General Meeting::Voluntary
2020-09-04
REPL::Extraordinary/ Special General Meeting::Voluntary
2020-08-28
REPL::Placements::UPDATED FINANCIAL EFFECTS OF THE PROPOSED PLACEMENT
2020-08-28
Financial Statements and Related Announcement::Full Yearly Results
2020-08-28
REPL::Extraordinary/ Special General Meeting::Voluntary
2020-08-27
REPL::Placements::PROPOSED PLACEMENT - CHANGE IN PARTICULARS OF SUBSCRIBER
2020-08-20
Placements::PROPOSED PLACEMENT - RECEIPT OF LISTING AND QUOTATION NOTICE
2020-08-10
Extraordinary/ Special General Meeting::Voluntary
2020-08-03
General Announcement::Allowance of WaferiX Patent by US Patent and Trademark Office Enhances Wafermine IP Protection
2020-07-28
Placements::PROPOSED PLACEMENT OF 44,491,299 NEW ORDINARY SHARES IN IX BIOPHARMA LTD.
2020-07-28
General Announcement::Request for Lifting of Trading Halt - Sponsor's Statement
2020-07-28
Request for Lifting of Trading Halt::Request for Lifting of Trading Halt
2020-07-27
Request for Trading Halt::Request for Trading Halt
2020-06-29
General Announcement::PRESS RELEASE: IX BIOPHARMA'S XATIVA RECORDS ROBUST UPTAKE FROM INITIAL PRODUCTION RUNS IN AUSTRALIA
2020-06-09
General Announcement::Notice of Allowance from United States Patent and Trademark Office for application covering WaferiX
2020-05-25
General Announcement::PRESS RELEASE: IX BIOPHARMA COMMENCES SUPPLY OF WAFESIL AND SILCAP IN AUSTRALIA THROUGH TELEMEDICINE
2020-05-08
General Announcement::UPDATE ON IMPACT OF COVID-19 ON BUSINESS OPERATIONS
2020-05-03
General Announcement::PRESS RELEASE: ENTITY SEES STRONG DEMAND FROM CHINA ON BOTH E-COMMERCE STORES
2020-04-28
General Announcement::Press Release: iX Biopharma inks agreement with Cannatrek to supply Xativa to the Australian market
2020-04-26
General Announcement::Press Release: Licensing, supply and distribution of Wafesil, sublingual sildenafil wafer, in China
2020-04-13
General Announcement::ENTITY EXPANDS NUTRACEUTICAL BUSINESS IN CHINA WITH LAUNCH OF SECOND FLAGSHIP E-COMMERCE STORE
2020-04-06
General Announcement::PRESS RELEASE - ENTITY COMMENCES SALE OF NUTRACEUTICALS TO CONSUMERS IN CHINA
2020-03-02
General Announcement::CESSATION OF QUARTERLY REPORTING
2020-02-11
Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results
2020-01-30
General Announcement::iX Biopharma Ltd. - Presentation for Phillip Securities - Jan 2020
2020-01-17
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2019-12-10
General Announcement::PRESS RELEASE - END-OF-PHASE 2 MEETING WITH THE U.S. FDA REGARDING WAFERMINE
2019-12-05
General Announcement::IX BIOPHARMA SECURES AUSTRALIAN CANNABIS MANUFACTURE LICENCE
2019-11-27
General Announcement::CHANGE IN COMPOSITION OF THE BOARD AND BOARD COMMITTEES OF THE COMPANY
2019-11-27
Change - Announcement of Appointment::Appointment of Non-Executive Independent Director
2019-11-26
Annual Reports and Related Documents::
«
Previous
2
3
4
5
6
»
Next
© 2025 Dividends.sg /
More Countries